Edition:
United Kingdom

Esperion Therapeutics Inc (ESPR.OQ)

ESPR.OQ on NASDAQ Stock Exchange Global Market

42.23USD
18 May 2018
Change (% chg)

$-0.55 (-1.29%)
Prev Close
$42.78
Open
$42.65
Day's High
$42.65
Day's Low
$41.20
Volume
114,106
Avg. Vol
314,213
52-wk High
$82.68
52-wk Low
$30.95

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -1.734
FY 2017 Dec '17 0.00 -1.444
Sep '17 0.00 -1.860
Jun '17 0.00 -1.918
Mar '17 0.00 -1.797
FY 2016 Dec '16 0.00 -1.284
Sep '16 0.00 -0.772
Jun '16 0.00 -0.623
Mar '16 0.00 -0.647
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 5 0.00 0.00 0.00 --
Quarter Ending Sep-18 5 0.00 0.00 0.00 --
Year Ending Dec-18 7 14.29 100.00 0.00 20.00
Year Ending Dec-19 8 62.50 250.00 0.00 85.02
Earnings (per share)
Quarter Ending Jun-18 9 -1.72 -1.50 -1.93 --
Quarter Ending Sep-18 9 -1.51 -1.37 -1.68 --
Year Ending Dec-18 10 -6.42 -6.05 -6.91 -4.36
Year Ending Dec-19 9 -5.17 -1.30 -6.74 -4.87
LT Growth Rate (%) 1 26.60 26.60 26.60 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 84.06 32.75
P/E High - Last 5 Yrs. -- 293.32 45.73
P/E Low - Last 5 Yrs. -- 91.63 24.23
Beta 2.67 0.90 0.88
Price to Sales (TTM) -- 110.95 5.71
Price to Book (MRQ) 8.24 13.58 5.37
Price to Tangible Book (MRQ) 9.37 14.04 6.94
Price to Cash Flow (TTM) -- 71.44 23.33
% Owned Institutions -- 12.71 2.16

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.51
Dividend 5 Year Growth Rate -- 1.66 5.32
Payout Ratio(TTM) -- 15.72 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 399.27 9.21
Sales (TTM) vs TTM 1 Yr. Ago -- 78.86 5.69
Sales - 5 Yr. Growth Rate -- 32.18 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago -208.10 25.14 19.38
EPS (TTM) vs TTM 1 Yr. Ago -138.27 -- --
EPS - 5 Yr. Growth Rate -- 39.01 10.77
Capital Spending - 5 Yr. Growth Rate 22.82 40.31 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.81 2.19
Current Ratio (MRQ) 5.52 5.29 2.98
LT Debt to Equity (MRQ) 0.09 22.98 12.17
Total Debt to Equity (MRQ) 1.24 24.63 16.44
Interest Coverage (TTM) -120.23 -99.39 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.04 54.45
Gross Margin - 5 Yr. Avg. -- 51.16 52.21
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -575.09 10.96
Operating Margin (TTM) -- -718.94 4.73
Operating Margin - 5 Yr. Avg. -- -596.41 6.40
Pre-Tax Margin (TTM) -- -693.40 5.57
Pre-Tax Margin - 5 Yr. Avg. -- -599.76 6.81
Net Profit Margin (TTM) -- -694.62 1.87
Net Profit Margin - 5 Yr. Avg. -- -602.62 3.09
Effective Tax Rate (TTM) -- 22.63 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.22 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,637,599 847,026,665
Net Income/Employee (TTM) -2,959,909 2,973,819 99,639,257
Receivable Turnover (TTM) -- 20.17 5.78
Inventory Turnover (TTM) -- 2.37 3.35
Asset Turnover (TTM) 0.00 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -56.29 -1.09 10.95
Return on Assets - 5 Yr. Avg. -30.70 -0.58 12.32
Return on Investment (TTM) -61.42 1.57 14.38
Return on Investment - 5 Yr. Avg. -32.77 2.21 16.11
Return on Equity (TTM) -61.71 2.43 16.07
Return on Equity - 5 Yr. Avg. -35.99 3.09 17.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -47.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Esperion Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 11.55 7.70 99 53
13 Week 20.24 14.38 99 65
26 Week 56.92 44.99 99 76
52 Week 315.45 252.13 99 50
YTD 348.96 294.28 99 58
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 237
Total Shares Held: 31,484,490
3 Mo. Net Change: 3,775,819
# New Positions: 37
# Closed Positions: 20
# Increased Positions: 119
# Reduced Positions: 93
# Net Buyers: 26
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.